Cardiovascular Health
CardiaViva reduces foam cell formation, lowers cholesterol levels, and decreases pro-inflammatory cytokines, targeting key factors in atherosclerosis and cardiovascular diseases. Its formulation supports heart health.
Contact Us1. Reduction in Foam Cell Formation
Preclinical experiments show that CardiaViva significantly reduces foam cell formation in human and mouse macrophages compared to untreated cells.
2. Lower Cholesterol and Cholesterol Ester Levels
CardiaViva effectively lowers total cholesterol, free cholesterol, and cholesterol ester levels in preclinical studies, outperforming untreated cells.
3. Reduction of Pro-Inflammatory Cytokines
CardiaViva significantly reduces IL-6 and IL-8 levels in mouse macrophages exposed to LPS, suggesting effective anti-inflammatory properties that could help in reducing atherosclerosis and CVD risk.